Exhibit 5
 | Walder Wyss Ltd. Seefeldstrasse 123 P.O. Box 8034 Zurich Switzerland Telephone +41 58 658 58 58 Fax +41 58 658 59 59 www.walderwyss.com |
To:
Auris Medical Holding AG
Bahnhofstrasse 21
6300 Zug
Switzerland
Zurich, as of 14 April 2017
Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8)
Dear Madam, Dear Sir,
We have acted as Swiss counsel to Auris Medical Holding AG, Zug, Switzerland (theCompany) in connection with the filing on the date hereof of a registration statement on Form S-8 (theRegistration Statement) by the Company with the U.S. Securities and Exchange Commission (theCommission) pursuant to the Securities Act of 1933, as amended (theSecurities Act) for the purpose of registering under the Securities Act the offer of 5,141,000 registered common shares, par value of CHF 0.40 each of the Company, which may be issued on the basis of the Company’s Conditional Share Capital (as defined below) after the date hereof pursuant to the Company’s equity incentive plan which was adopted by the Company’s board of directors on 13 April 2017 (theEquity Incentive Plan) (such shares, theSharesand each aShare).
As such counsel, we have been requested to render an opinion as to certain matters of Swiss law.
| Attorneys admitted in Switzerland or in a EU/EFTA state are registered with the attorneys' registry | Page 1 of 6 |
 | Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8) |
| 1. | Scope and Limitation of Opinion |
Our opinion is strictly confined to matters of Swiss law as in force at the date hereof and as it is presently applied by the Swiss courts. Such law and its interpretation are subject to change. In the absence of explicit statutory law or established case law, we base our opinion solely on our independent professional judgment.
Our opinion is strictly limited to the Documents (as defined below) and the matters stated herein and is not to be read as extending, by implication or otherwise, to any agreement or document referred to in any of the Documents or any other matter.
For purposes of this opinion, we have not conducted any due diligence or similar investigation or verification as to any matters stated herein.
In this opinion, Swiss legal concepts are expressed in English terms and not in their original language. These concepts may not be identical to the concepts described by the same English language terms as they exist under the laws of other jurisdictions.
For purposes of rendering the opinion expressed herein, we have received the following documents (theDocuments):
| (a) | a .pdf copy of the Registration Statement; |
| (b) | a .pdf copy of the Equity Incentive Plan; |
| (c) | a .pdf copy of the resolution of the board of directors of the Company dated 13 April 2017 approving, among others, the adoption of the Equity Incentive Plan (theBoard Resolution); |
| (d) | a .pdf copy of the certified articles of incorporation of the Company in their version of 13 April 2017 (theArticles); |
| (e) | a .pdf copy of the resolution of the Company’s shareholders’ meeting, dated 13 April 2017 approving, among others, the amendments to the |
| | Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8) |
authorized share capital and the conditional share capital of the Company under its articles of association (theAGM Resolution); and
| (f) | a .pdf copy of a certified excerpt from the daily registry (Tagebuchauszug) of the Commercial Register of the Canton of Zug dated 13 April 2017 relating to recording of the revised articles of association as per the AGM Resolution (theExcerpt). |
No documents have been reviewed by us in connection with this opinion other than the Documents listed in this Section 2 (Documents).
All terms used in this opinion in uppercase form shall have the meaning ascribed to them in the Registration Statement, unless otherwise defined herein.
In rendering the opinion below, we have assumed:
| (a) | the conformity to the Documents of all documents produced to us as copies, fax copies or via e-mail, and that the original was executed in the manner appearing on the copy of the draft; |
| (b) | the genuineness and authenticity of the signatures on all copies of the original Documents thereof which we have examined, and the accuracy of all factual information contained in, or material statements given in connection with, the Documents; |
| (c) | the Board Resolutions have been duly resolved in meetings duly convened, or, respectively, in duly executed circular resolutions and have not been rescinded or amended and are in full force and effect; |
| (d) | the AGM Resolution has been duly resolved in a meeting duly convened and has not been rescinded or amended and is in full force and effect; |
| (e) | the Registration Statement and the Equity Incentive Plan have been duly filed by the Company; |
| (f) | the Articles and the Excerpt are unchanged and correct as of the date hereof and no changes have been made which should have been or should be reflected in the Articles and the Excerpt as of the date hereof; |
| | Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8) |
| (g) | the exercise notice with respect to the Shares to be issued out of the Conditional Share Capital of the Company will be duly delivered in accordance with the Equity Incentive Plan; |
| (h) | the payment of the exercise price in connection with an exercise notice relating to Shares will be made in accordance with the Equity Incentive Plan; and |
| (i) | if and to the extent the Shares are to be issued out of the Company’s Conditional Share Capital, such Shares are and will be issued and fully paid up in compliance with the laws of Switzerland. |
| | Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8) |
Based upon the foregoing and subject to the qualifications set out below, we are of the following opinion:
The Company’s conditional share capital for equity incentive plans under article 3b para. 3 of the Articles (theConditional Share Capital) provides the Company with the authority to issue up to 6,500,000 registered common shares with a par value of CHF 0.40 each for purposes of the Equity Incentive Plan without the requirement of further approval in connection with the Equity Incentive Plan. If and to the extent the Shares are issued out of the Conditional Share Capital of the Company pursuant to the Equity Incentive Plan, such Shares will be validly issued, fully paid and non-assessable.
The above opinions are subject to the following qualifications:
| (a) | The lawyers of our firm are members of the Swiss bar and do not hold themselves to be experts in any laws other than the laws of Switzerland. Accordingly, we are opining herein as to Swiss law only and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction. |
| (b) | This opinion is based on the current provisions of the laws of Switzerland and the regulations thereunder in effect on the date hereof and only as currently interpreted in Switzerland. Such laws and their interpretation are subject to change. |
| (c) | We express no opinion as regards the withdrawal of the shareholders’ preferential subscription rights (Vorwegzeichnungsrechte) in connection with any issuance of Shares. |
| (d) | When used in this opinion, the term “non-assessable” means that no further contributions have to be made to the Company by the relevant holder of the Shares. |
| (e) | We express no opinion as to the future availability of conditional share capital of the Company. |
| | Auris Medical Holding AG – Swiss Legal Opinion (Registration Statement on Form S-8) |
| (f) | Any issuance of the Shares out of conditional share capital must be confirmed by the auditor of the Company, and amended articles of association of the Company reflecting the issuance of Shares out of the conditional share capital, together with ascertainments by the Company's board of directors in a public deed and said confirmation by the Company's auditor, must be filed with the competent commercial register no later than three months after the end of the Company's fiscal year. |
| (g) | We express no opinion as to the accuracy or completeness of the information contained in the Registration Statement. |
| (h) | We express no opinion as to any commercial, calculating, auditing or other non-legal matters. Further, we express no opinion as to tax law. |
| (a) | We do not assume any obligation to advise you of any changes in applicable law or any other matter that may come to our attention after the date hereof that may affect our opinion expressed herein. |
| (b) | We hereby consent to the filing of this opinion on the date hereof with the Commission as an exhibit to the Registration Statement and to the incorporation by reference of this opinion in the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act. |
| (c) | This opinion is governed by and shall be construed in accordance with the substantive laws of Switzerland, the ordinary Courts of Zurich having exclusive jurisdiction. |
| Yours faithfully, |
| |
| /s/ Alex Nikitine | /s/Markus Pfenninger |
| Alex Nikitine | Markus Pfenninger |
